Related Experiment Video
Updated: Aug 8, 2026

05:26
Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
Published on: May 28, 2019
[Postconditioning: lethal reperfusion injury as a therapeutic target]
1Hôpital cardiologique et pneumologique, Louis-Pradel, 59, boulevard Pinel, 69394 Lyon 03, Lyon, France. ovize@sante.univ-lyon1.fr
Summary
Ischemic postconditioning significantly reduces heart attack damage by using brief reperfusion periods. This cardioprotective method may involve specific cell signaling pathways, offering hope for new treatments.
Area of Science:
- Cardiology
- Cellular Biology
- Pharmacology
Context:
- Acute myocardial infarction (AMI) is a primary cause of death globally.
- Ischemic postconditioning is a cardioprotective strategy involving brief reperfusion episodes after prolonged ischemia.
- Current treatments aim to limit infarct size and preserve cardiac function.
Purpose:
- To summarize the protective mechanisms of ischemic postconditioning.
- To highlight its potential in reducing infarct size in acute myocardial infarction.
- To explore the development of pharmacological agents mimicking postconditioning.
Summary:
- Ischemic postconditioning, a technique of repeated brief ischemia-reperfusion, significantly reduces infarct size following acute myocardial infarction.
- This cardioprotective effect is associated with the activation of the PI3-kinase-Akt-eNOS signaling pathway and inhibition of the mitochondrial permeability transition pore.
- A recent clinical study confirmed the protective benefits of postconditioning in the human heart.
Impact:
- Provides a foundation for developing novel pharmacological therapies for acute myocardial infarction.
- Suggests that mimicking postconditioning could offer a new treatment strategy for patients with ongoing heart attacks.
- Emphasizes the need for further research into pharmacologic agents that replicate postconditioning's benefits.

